Tag: ascendis pharma

November 29, 2018

Ascendis Pharma Reports Third Quarter 2018 Financial Results

Ascendis Pharma (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technology to address significant unmet medical needs, today announced financial...
November 29, 2018

Ascendis Pharma Announces Positive Preliminary Phase 1 Data for TransCon CNP

Ascendis Pharma (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technology to address significant unmet medical needs, today announced positive...
June 7, 2018

Ascendis Pharma Announces Orphan Drug Designation Granted for TransCon PTH as Treatment for Hypoparathyroidism

Ascendis Pharma (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs, today announced...